The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-methyl-2-(3-(4-((methyl(2-(methylamino)ethyl)amino)methyl)-1H-pyrazol-5-yl)-5-(trifluoromethyl)phenoxy)pentan-1-ol ID: ALA3589038
Max Phase: Preclinical
Molecular Formula: C21H31F3N4O2
Molecular Weight: 428.50
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CNCCN(C)Cc1cn[nH]c1-c1cc(OC(CO)CC(C)C)cc(C(F)(F)F)c1
Standard InChI: InChI=1S/C21H31F3N4O2/c1-14(2)7-19(13-29)30-18-9-15(8-17(10-18)21(22,23)24)20-16(11-26-27-20)12-28(4)6-5-25-3/h8-11,14,19,25,29H,5-7,12-13H2,1-4H3,(H,26,27)
Standard InChI Key: FYZDIUPNFFHKJM-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 31 0 0 0 0 0 0 0 0999 V2000
3.9511 -0.8815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5987 -1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7343 -2.9815 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2010 -3.2956 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9531 -1.9978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2568 0.5852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6819 1.0556 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5772 0.2566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9880 2.5249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4132 2.9954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7193 4.4647 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0031 3.0008 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3039 3.7494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6039 2.9994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8588 4.8408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5988 -1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6384 -0.9011 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-2.5984 -2.7004 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.6377 -2.1009 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-1.3070 5.2502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6078 5.9988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6103 7.1988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6460 5.3969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6433 3.5990 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 2 0
5 1 1 0
1 6 1 0
6 7 1 0
2 8 1 0
7 9 1 0
7 10 1 0
10 11 1 0
11 12 1 0
8 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 8 1 0
14 18 1 0
18 19 1 0
19 20 1 0
12 21 1 0
16 22 1 0
22 23 1 0
22 24 1 0
22 25 1 0
19 26 1 0
26 27 1 0
27 28 1 0
27 29 1 0
20 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 428.50Molecular Weight (Monoisotopic): 428.2399AlogP: 3.53#Rotatable Bonds: 11Polar Surface Area: 73.41Molecular Species: BASEHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.24CX Basic pKa: 9.91CX LogP: 2.89CX LogD: 0.66Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.51Np Likeness Score: -0.81
References 1. Mitchell LH, Drew AE, Ribich SA, Rioux N, Swinger KK, Jacques SL, Lingaraj T, Boriack-Sjodin PA, Waters NJ, Wigle TJ, Moradei O, Jin L, Riera T, Porter-Scott M, Moyer MP, Smith JJ, Chesworth R, Copeland RA.. (2015) Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool Compound., 6 (6): [PMID:26101569 ] [10.1021/acsmedchemlett.5b00071 ]